Directed evolution of metalloproteinase inhibitor TIMP-1 for selective inhibition of MMP-9 exploits catalytic and fibronectin domain interactions is a research paper published in Journal of Biological Chemistry (2025). On theSindex it has a DataRank of 0.360. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart Lung and Blood Institute
Grant: R01HL157424
National Institutes of Health National Cancer Institute
Grant: R01CA258274
NIH National Institute of General Medical Sciences
Grant: R01GM132100
National Institutes of Health
Grant: 5R01CA258274-02
Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy
National Institutes of Health
Grant: 5R01GM132100-03
Engineering selective inhibition of metalloproteinases by tissue inhibitors of metalloproteinases (R01 GM132100 RESUB - *TIMPs)
National Institutes of Health
Grant: 1R01HL157424-01A1
Proteolysis in the Pathogenesis of ARDS
National Institutes of Health
Grant: 5T34GM145385-02
U-RISE at University of North Florida
FWCI
4.43
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords